Recombinant activated factor VIIa treatment for refractory hemorrhage in infants

Journal of Perinatology

Volumn 31, Issue 3, 2011, Pages 188-192

  Dang, C N ^a   Katakam, L I ^a,b   Smith, P B ^a,b,c   Cotten, C M ^a,b   Goldberg, R N ^a,b   Chandler, N ^a   Thornburg, C D ^a   Bidegain, M ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Jean and George W Brumley Jr Neonatal Perinatal Research Institute   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

blood products; coagulation factors; infants; transfusion

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BIRTH WEIGHT; BLEEDING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; ERYTHROCYTE CONCENTRATE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HEMOSTASIS; HUMAN; LUNG HEMORRHAGE; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN TIME; SINGLE DRUG DOSE; SKIN BLEEDING; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOSIS;

BLOOD TRANSFUSION; FACTOR VIIA; FEMALE; GESTATIONAL AGE; HEMORRHAGE; HUMANS; INFANT, NEWBORN; MALE; RECOMBINANT PROTEINS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79952310927     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.85     Document Type: Article

References (31)

1. Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K et al. Pharmacokinetics and pharmacodynamics of recombinant Factor VIIa. Clinical Pharmacology & Therapeutics 1994; 55(6): 638-648. (Pubitemid 24212264)
2. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33(1): 179-201. (Pubitemid 16135483)
3. Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater Jr DC, He Y et al. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. Ann Thorac Surg 2007; 84(1): 168-169.
4. Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK. Pediatric off-label use of recombinant factor VIIa. Pediatrics 2009; 123(3): 1066-1072.
5. Veldman A, Neuhaeuser C, Akintuerk H, Thul J, Gehron J, Schranz D et al. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease. Paediatr Anaesth 2007; 17(12): 1123-1125.
6. Heller M, Lau W, Pazmino-Canizares J, Brandao LR, Carcao M. A comprehensive review of rFVIIa use in a tertiary care pediatric center. Pediatr Blood Cancer 2008; 50(5): 1013-1017. (Pubitemid 351500180)
7. Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. Paediatr Anaesth 2009; 19(4): 364-370.
8. Yilmaz D, Karapinar B, Balkan C, Akisu M, Kavakli K. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Pediatr Hematol Oncol 2008; 25(4): 301-311. (Pubitemid 351874077)
9. Grizelj R, Vukovic J, Filipovic-Grcic B, Saric D, Luetic T. Successful use of recombinant activated FVIIa and aminocaproic acid in four neonates with life-threatening hemorrhage. Blood Coagul Fibrinolysis 2006; 17(5): 413-415. (Pubitemid 43941585)
10. Jen H, Shew S. Recombinant activated factor VII use in critically ill infants with active hemorrhage. J Pediatr Surg 2008; 43(12): 2235-2238.
11. Tancabelic J, Haun SE. Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7. Pediatr Blood Cancer 2004; 43(2): 170-176. (Pubitemid 38891166)
12. Ekert H, Brizard C, Eyers R, Cochrane A, Henning R. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard hemostatic replacement therapy. Blood Coagul Fibrinolysis 2006; 17(5): 389-395. (Pubitemid 43941581)
13. Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H et al. Recombinant factor VIIa (Novosevens) as a hemostatic agent after surgery for congenital heart disease. Pediatric Anesth 2005; 15: 235-240. (Pubitemid 40364750)
14. Velik-Salchner C, Sergi C, Fries D, Moser P, Streif W, Kolbitsch C. Use of recombinant factor VIIa (Novoseven) in combination with other products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation. Anesth Analg 2005; 101: 924. (Pubitemid 41208540)
15. Wittenstein B, Ng C, Ravn H, Goldmann A. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. Pediatr Crit Care Med 2005; 6: 473-476. (Pubitemid 40980831)
16. Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. Blood Coagul Fibrinolysis 2006; 17(3): 213-216.
17. Olomu N, Kulkarni R, Manco-Johnson M. Treatment of Severe Pulmonary Hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. J Perinatol 2002; 22: 672-674. (Pubitemid 36150231)
18. Hunseler C, Kribs A, Eifinger F, Roth B. Recombinant activated factor VII in acute lifethreatening bleeding neonates: report on three cases and review of the literature. J Perinatol 2006; 26: 706-713. (Pubitemid 44650190)
19. Filan PM, Mills JF, Clarnette TD, Ekert H, Ekert P. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa. J Pediatr 2005; 147: 857-859. (Pubitemid 41774849)
20. Brady KM, Easley RB, Tobias JD. Recombinant activated factor VII treatment in infants with hemorrhage. Ped Anesthesia 2006; 16: 1042-1046. (Pubitemid 44401171)
21. Girisch M, Rauch R, Carbon R, Habash T, Hofbeck M. Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa. Eur J Pediatr 2004; 163(2): 118-119. (Pubitemid 38223397)
22. Fischer D, Schloesser R, Buxmann H, Veldman A. Recombinant activated factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation. J Pediatr Hematol Oncol 2008; 5: 337-342. (Pubitemid 351643454)
23. Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. J Pediatr Hematol Oncol 2007; 29(3): 145-150. (Pubitemid 46673399)
24. Yilmaz D, Karapinar B, Balkan C, Akisu M, Kavakli K. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Pediatr Hematol Oncol 2008; 25(4): 301-311. (Pubitemid 351874077)
25. Altuncu E, Berrak S, Bilgen H, Yurdakul Z, Canpolat C, Ozek E. Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma. J Matern Fetal Neonatal Med 2007; 20(8): 627-629. (Pubitemid 47221558)
26. Abdullah F, Hunter C, Hargrove C, Arnold M, Stein J. Recombinant factor VIIa for treatment of massive liver fracture in a premature infant. J Pediatr Surg 2006; 41(10): 1764-1767. (Pubitemid 44441363)
27. Young G, Wicklund B, Neff P, Johnson C, Nugent DJ. Off-label use of rFVIIa in children with excessive bleeding: a consecutive study of 153 off-label uses in 139 children. Pediatr Blood Cancer 2009; 53: 178-183.
28. Manco-Johnson M, Nuss R. Hemostasis in neonates. Neoreviews 2000; 1: e191-e195.
29. Tripodi A, Ramenghi LA, Chantarangkul V, De Carli A, Clerici M, Groppo M et al. Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests. Haematologica 2008; 93: 1256-1259.
30. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006; 295: 293-298. (Pubitemid 43112957)
31. Puetz J, Darling G, Brabec P, Blatny J, Mathew P. Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. Pediatr Blood Cancer 2009; 53: 1074-1078.